drugset / Trial / NCT00698828
SUN11031 in Cachexia Associated With Chronic Obstructive Pulmonary Disease (COPD)
RandomizedParallel-groupDouble-blindTreatment
Summary
To evaluate SUN11031 for subcutaneous injection compared to placebo in subjects with cachexia associated with Chronic Obstructive Pulmonary Disease (COPD) to determine the effect on physical performance and body composition.
Timeline
- Start
- 2008-05-15
- Primary completion
- 2009-10-08
- Completion
- 2009-10-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SUN11031 | Unknown | 20 ug/kg | Subcutaneous |
| Subject | SUN11031 | Unknown | 40 ug/kg | Subcutaneous |